Gene: ATF6B
Official Full Name: activating transcription factor 6 betaprovided by HGNC
Gene Summary: The protein encoded by this gene is a transcription factor in the unfolded protein response (UPR) pathway during ER stress. Either as a homodimer or as a heterodimer with ATF6-alpha, the encoded protein binds to the ER stress response element, interacting with nuclear transcription factor Y to activate UPR target genes. The protein is normally found in the membrane of the endoplasmic reticulum; however, under ER stress, the N-terminal cytoplasmic domain is cleaved from the rest of the protein and translocates to the nucleus. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01348 | ATF6B Knockout cell line (HeLa) | Human | ATF6B | 1:3~1:6 | Negative | Online Inquiry |
KO10438 | ATF6B Knockout cell line (HCT 116) | Human | ATF6B | 1:2~1:4 | Negative | Online Inquiry |
KO10439 | ATF6B Knockout cell line (HEK293) | Human | ATF6B | 1:3~1:6 | Negative | Online Inquiry |
KO10440 | ATF6B Knockout cell line (A549) | Human | ATF6B | 1:3~1:4 | Negative | Online Inquiry |
ATF6B Gene Knockout Cell Lines are genetically engineered cell lines designed to facilitate the study of the ATF6B gene's role in cellular processes, particularly those associated with the unfolded protein response (UPR) and endoplasmic reticulum (ER) stress. By utilizing CRISPR/Cas9 technology, these knockout cell lines allow researchers to precisely eliminate the ATF6B gene, enabling the investigation of its function in both normal physiology and disease states.
The primary function of ATF6B is to respond to ER stress by promoting adaptive signaling that ensures cellular homeostasis. When the UPR is activated due to an accumulation of misfolded proteins, ATF6B plays a critical role in modulating gene expression to alleviate stress. By using our ATF6B Gene Knockout Cell Lines, researchers can directly assess changes in cell viability, stress response, and metabolic alterations in the absence of this important regulator, thereby deepening their understanding of conditions such as neurodegenerative diseases, diabetes, and cancer.
The scientific importance of these cell lines extends to both basic and translational research, providing an invaluable tool for elucidating the mechanisms of ER stress and UPR-related diseases. Furthermore, they can serve as a platform for drug screening, allowing for the identification of therapeutic agents that can modulate the UPR.
What sets our ATF6B Gene Knockout Cell Lines apart from alternatives is the precision of our knockout method and the high level of consistency in cell performance. These lines are rigorously characterized to ensure stability and reproducibility, critical factors for researchers aiming for credible results. Moreover, our dedicated customer support and expertise in gene editing technology emphasize our commitment to advancing scientific research.
In summary, our ATF6B Gene Knockout Cell Lines represent an essential resource for researchers and clinicians seeking to explore the multifaceted roles of the ATF6B gene in health and disease, backed by our company’s extensive experience in providing high-quality biological products.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.